H Lee Moffitt Cancer Center and Research Institute HLM — Tampa, Florida

H Lee Moffitt Cancer Center and Research Institute HLM is a clinical research site located in Tampa, Florida, United States 33612.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

H Lee Moffitt Cancer Center and Research Institute HLM has participated in 1 clinical trials.

Therapeutic areas: Advanced NET of GI Origin, Advanced NET of Lung Origin, Neuroendocrine Tumors.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tampa

Browse all research sites in Florida · View every site in Tampa

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for H Lee Moffitt Cancer Center and Research Institute HLM?

H Lee Moffitt Cancer Center and Research Institute HLM has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has H Lee Moffitt Cancer Center and Research Institute HLM conducted?

H Lee Moffitt Cancer Center and Research Institute HLM has 1 clinical trials on record. Their work covers Advanced NET of GI Origin, Advanced NET of Lung Origin, Neuroendocrine Tumors.

Is H Lee Moffitt Cancer Center and Research Institute HLM accredited by Crixeo Clinical Trials?

H Lee Moffitt Cancer Center and Research Institute HLM has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about H Lee Moffitt Cancer Center and Research Institute HLM?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.